Eli Lilly said on Tuesday its drug, Jaypirca, was more effective in a head-to-head study against AbbVie's Imbruvica when tested in patients with a type of blood cancer. The drug was being tested in ...

Competition in the blockbuster weight loss drug market is ramping up, as drugmakers share fresh data on new and existing treatments. Stream San Diego News for free, 24/7, wherever you are with NBC 7.

Eli Lilly & Co. is suing four telehealth companies selling compounded versions of tirzepatide, the active ingredient in Lilly's weight-loss drug Zepbound and diabetes drug Mounjaro.

HAYA Therapeutics Moves San Diego Operations to Lilly Gateway Labs® to Accelerate Development of RNA-Guided Therapeutics Platform Provided by Business Wire Jun 3, 2025, 5:02:00 AM ...

PEREZ, LILLY BELL MILTON Oceanside – Lilly Perez passed away on Saturday, February 28, 2009, at Tri-City Hospital with family and loved ones at her bedside. Born in Center, Texas, on December… ...

Eli Lilly’s stock wobbled Thursday after a looming coverage hit was detailed for its blockbuster weight-loss drug Zepbound. CVS Health said the drugs Wegovy and Saxenda from rival drugmaker Novo ...

Eli Lilly and Company World Headquarters. (Jonathan Weiss/JetCity Image/Dreamstime/TN) By Paul Sisson | [email protected] | The San Diego Union-Tribune UPDATED: June 23, 2025 at 5:58 ...

Reuters FILE PHOTO: Lilly Biotechnology Center is shown in San Diego, California, U.S. March 1, 2023, after Eli Lilly and Co on Wednesday said it will cut list prices by 70% for its most commonly ...

Eli Lilly acquires SiteOne Therapeutics for up to $1 billion, signaling potential uptick in Big Pharma deals and focus on nonopioid pain treatments.